FBIO

Fortress Biotech (FBIO)

About Fortress Biotech (FBIO)

Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.

Details

Daily high

$1.63

Daily low

$1.56

Price at open

$1.57

52 Week High

$4.43

52 Week Low

$1.24

Market cap

43.6M

Dividend yield

0.00%

Volume

88,954

Avg. volume

886,751

P/E ratio

-.10

Fortress Biotech News